Sulfonylalkanoylamino hydroxyethylamimo sulfonamides useful as retroviral protease inhibitors
US5965588A · kind A · utility
38Cited by
5References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 26, 1998 |
| Grant date | Oct 12, 1999 |
| Priority date | — |
| Expiry date | Mar 26, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C317/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Sulfonamide-containing hydroxyethylamine compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.